Zetia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

In Silico Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in French Patients With Established Cardiovascular Disease
Condition:   Atherosclerotic Cardiovascular Disease Interventions:   Drug: Inclisiran sodium;   Drug: Placebo;   Drug: Ezetimibe;   Drug: Evolocumab Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2023 Category: Research Source Type: clinical trials